본문 바로가기 대메뉴 바로가기
ILHAN LIM(Professor)

INFO

  • AffiliationKorea Institute of Radiological & Medical Sciences
  • Majors Radiological & Medico-Oncological Sciences
  • Contact Information02-970-2241
  • Major핵의학
  • DegreePh.D.
  • Highest Level of Education서울대학교
  • E-Mail

Field of Research

Targeted treatment using radiolabeling antibody

Research Results

-  The combination of FDG PET and dynamic contrast-enhanced MRI improved the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy, Eur J Nucl Med Mol Imaging, 2014 Oct;41(10):1852-60. -  Prognostic Significance of Pre-treatment F-18-FDG PET/CT in patients with Relapsed/Refractory B-cell non-Hodgkin’s Lymphoma treated by Radioimmunotherapy using I-131-rituximab, Acta Hematologica, 2013; 130: 74-82. -  Ilhan Lim, Keon Wook Kang, Dong Soo Lee, et al., Extravasation of hydroxymethylene diphosphonate (HDP) induced subcutaneous inflammation, histologically demonstrated in Balb/C mice, Journal of Nuclear Medicine. 2010; 51:1573-1575.

Book(in last five years)

-  미래사회의 방사선의학[2016-05-15]

Treatise

-  The combination of FDG PET and dynamic contrast-enhanced MRI improved the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy[Eur J Nucl Med Mol Imaging,2014-10-01] -  Image-Based Dosimetry of Radionuclide Therapy[Journal of Korean Thyroid Association,2013-06-05] -  Prognostic value of 18?F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer[Eur J Nucl Med Mol Imaging,2014-07-09] -  Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹?F-FDG PET/CT and MRI[Eur J Nucl Med Mol Imaging,2014-08-12] -  Comparison of (18)F-FDG PET/CT and (99m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma[2013-12-05] -  Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.[Journal of Nuclear Medicine,2013-07-10] -  Initial Metabolic Tumor Volume Measured by 18F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities[Journal of Nuclear Medicine,2013-10-08] -  Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.[Cancer Chemother Pharmacol.,2013-04-04] -  (18)F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma[Eur J Nucl Med Mol Imaging,2013-05-08] -  Perirenal F18-FDG uptake in a patient with a pheochromocytoma[Nuclear Medicine and Molecular Imaging ,2014-09-01] -  Usefulness of increased F-18 FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement [ SKELETAL RADIOLOGY,2015-04-01] -  Prediction of response to neoadjuvant chemotherapy i nosteosarcoma using dual-phase F-18 FDG PET/CT[ EUROPEAN RADIOLOGY,2015-07-01] -  PET evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain[BIOMED RESEARCH INTERNATIONAL,2016-01-01] -  Prognostic value of SUVmax measured by pretreatment F-18 FDG PET/CT in patients with Ewing sarcoma[PLOS ONE,2016-09-01] -  RIT with I-131 rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma[ CANCER CHEMOTHERAPY AND PHARMACOLOGY,2016-10-01] -  Prognostic value of SUVmax measured by pretreatment FDG PET/CT in patients with primary gastric lymphoma[NUCLEAR MEDICINE COMMUNICATIONS,2016-12-01]